Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.

Cohen JD, Labenski M, Mastrandrea NJ, Canatsey RD, Monks TJ, Lau SS.

Mol Carcinog. 2016 Aug;55(8):1243-50. doi: 10.1002/mc.22366. Epub 2015 Aug 31.

2.

TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium.

Zhou Y, Rychahou P, Wang Q, Weiss HL, Evers BM.

Cell Death Dis. 2015 Feb 5;6:e1631. doi: 10.1038/cddis.2014.588.

3.

Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.

Back SJ, Andronikou S, Kilborn T, Kaplan BS, Darge K.

Pediatr Radiol. 2015 Mar;45(3):386-95. doi: 10.1007/s00247-014-3147-1. Epub 2014 Oct 30.

PMID:
25355409
4.

Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells.

Spampatti M, Vlotides G, Spöttl G, Maurer J, Göke B, Auernhammer CJ.

World J Gastroenterol. 2014 Aug 7;20(29):10038-49. doi: 10.3748/wjg.v20.i29.10038.

5.

Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.

Shin J, Yang J, Lee JC, Baek KH.

Cell Signal. 2013 Dec;25(12):2540-7. doi: 10.1016/j.cellsig.2013.08.014. Epub 2013 Aug 30.

PMID:
23993963
6.

Resistance exercise, but not endurance exercise, induces IKKβ phosphorylation in human skeletal muscle of training-accustomed individuals.

Møller AB, Vendelbo MH, Rahbek SK, Clasen BF, Schjerling P, Vissing K, Jessen N.

Pflugers Arch. 2013 Dec;465(12):1785-95. doi: 10.1007/s00424-013-1318-9. Epub 2013 Jul 10.

PMID:
23838844
7.

A magnetic resonance imaging study of cerebellar volume in tuberous sclerosis complex.

Weisenfeld NI, Peters JM, Tsai PT, Prabhu SP, Dies KA, Sahin M, Warfield SK.

Pediatr Neurol. 2013 Feb;48(2):105-10. doi: 10.1016/j.pediatrneurol.2012.10.011.

8.

Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.

Martignoni G, Bonetti F, Chilosi M, Brunelli M, Segala D, Amin MB, Argani P, Eble JN, Gobbo S, Pea M.

Mod Pathol. 2012 Jan;25(1):100-11. doi: 10.1038/modpathol.2011.136. Epub 2011 Aug 26.

9.

ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Cohen JD, Gard JM, Nagle RB, Dietrich JD, Monks TJ, Lau SS.

Toxicol Sci. 2011 Nov;124(1):75-87. doi: 10.1093/toxsci/kfr203. Epub 2011 Aug 2.

10.

cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Cohen JD, Tham KY, Mastrandrea NJ, Gallegos AC, Monks TJ, Lau SS.

Toxicol Sci. 2011 Aug;122(2):361-71. doi: 10.1093/toxsci/kfr118. Epub 2011 Jun 20.

11.

Suppression of tumor suppressor Tsc2 and DNA repair glycosylase Nth1 during spontaneous liver tumorigenesis in Long-Evans Cinnamon rats.

Sajankila SP, Manthena PV, Adhikari S, Choudhury S, Izumi K, Roy R.

Mol Cell Biochem. 2010 May;338(1-2):233-9. doi: 10.1007/s11010-009-0357-1. Epub 2009 Dec 24.

12.

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.

Missiaglia E, Dalai I, Barbi S, Beghelli S, Falconi M, della Peruta M, Piemonti L, Capurso G, Di Florio A, delle Fave G, Pederzoli P, Croce CM, Scarpa A.

J Clin Oncol. 2010 Jan 10;28(2):245-55. doi: 10.1200/JCO.2008.21.5988. Epub 2009 Nov 16.

13.

Autophagy induced by suberoylanilide hydroxamic acid in Hela S3 cells involves inhibition of protein kinase B and up-regulation of Beclin 1.

Cao Q, Yu C, Xue R, Hsueh W, Pan P, Chen Z, Wang S, McNutt M, Gu J.

Int J Biochem Cell Biol. 2008;40(2):272-83. Epub 2007 Aug 10.

PMID:
17881280
14.

Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development.

Cai S, Everitt JI, Kugo H, Cook J, Kleymenova E, Walker CL.

Am J Pathol. 2003 Feb;162(2):457-68.

15.

MR evaluation of the hippocampus in patients with congenital malformations of the brain.

Sato N, Hatakeyama S, Shimizu N, Hikima A, Aoki J, Endo K.

AJNR Am J Neuroradiol. 2001 Feb;22(2):389-93.

16.

Chromosomal assignment of canine TSC2, PKD1 and CLN3 genes by radiation hybrid- and linkage analyses.

Jónasdóttir TJ, Mellersh CS, Moe L, Vignaux F, Ostrander EA, Lingaas F.

Anim Genet. 2000 Apr;31(2):123-6.

PMID:
10782211
17.

Novel intragenic polymorphisms in the tuberous sclerosis 2 (TSC2) gene. Mutations in brief no. 184. Online.

Astrinidis A, Kouvatsi A, Nahmias J, Povey S, Pandeliadis C, Danzaki A, Schneider M, Triantaphyllidis C.

Hum Mutat. 1998;12(3):217.

PMID:
10660335
18.

Cloning and characterization of a mouse homologue (mNthl1) of Escherichia coli endonuclease III.

Sarker AH, Ikeda S, Nakano H, Terato H, Ide H, Imai K, Akiyama K, Tsutsui K, Bo Z, Kubo K, Yamamoto K, Yasui A, Yoshida MC, Seki S.

J Mol Biol. 1998 Oct 2;282(4):761-74.

PMID:
9743625
19.

Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.

Wienecke R, Maize JC Jr, Reed JA, de Gunzburg J, Yeung RS, DeClue JE.

Am J Pathol. 1997 Jan;150(1):43-50.

20.

Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.

Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC Jr, Welsh CT, Norman MG, DeClue JE, Vinters HV.

Brain Pathol. 1996 Oct;6(4):367-75.

PMID:
8944308

Supplemental Content

Loading ...
Support Center